[Premature rupture of the membranes. Analysis of neonatal infection].
The study included 65 pregnant women with PRM and of 23 (control group) without PRM or infection. Out of the products from PRM, infection appeared in 13.2% and from the control group in 4.2% (p less than 0.001). No differences were found among frequency of infection and the various periods of latency of PRM, nor with the route from which the product was obtained. The overall mortality was 5.8% for the group studied and cero for the control group (p greater than 0.05) and was shown to be more related with prematurity than with the latent period of PRM. With these experiences, the prophylactic use of antibiotics is not justified in the newborn from mother with PRM.
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000453:epidemiology*; D008431:Maternal-Fetal Exchange; D008800:Mexico; D007752:Obstetric Labor, Premature / Q000150:complications*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy
Ruptura prematura de membranas. Análisis de la infección neonatal